Filing Details
- Accession Number:
- 0001140361-10-049239
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-10 19:54:40
- Reporting Period:
- 2010-12-09
- Filing Date:
- 2010-12-10
- Accepted Time:
- 2010-12-10 19:54:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc | EXEL | Services-Commercial Physical & Biological Research (8731) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1213140 | Gisela Schwab | C/O Exelixis Inc. 170 Harbor Way, Po Box 511 South San Francisco CA 94083-0511 | Evp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-12-09 | 4,112 | $6.50 | 7,322 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,275 | Indirect | By 401(k) Plan |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 26, 2010.
- Shares acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan.
- Includes 7,322 shares of common stock acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan.
- Represents 3,274 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated December 9, 2010.
Billionaire Hedge Funds
